ac devd afc (MedChemExpress)
Structured Review

Ac Devd Afc, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/devd+afc/Ac-DEVD-AFC/pmc12997193-46-32-44
Average 94 stars, based on 16 article reviews
Images
1) Product Images from "Rational payload selection enables high antitumoral efficacy of an anti-EGFR antibody-drug conjugate against ovarian tumors"
Article Title: Rational payload selection enables high antitumoral efficacy of an anti-EGFR antibody-drug conjugate against ovarian tumors
Journal: Neoplasia (New York, N.Y.)
doi: 10.1016/j.neo.2026.101295
Figure Legend Snippet: Action of cetuximab-vc-MMAF on cell viability. A. Flow cytometry-based apoptosis assay of cells treated with the cetuximab-vc-MMAF (10 nM) for the indicated times. Live cells are shown in the lower left quadrant (Annexin V-/PI-), while the other three quadrants represent different stages of non-viable cells. B. Graphical representation of non-viable cells for each condition. Data are plotted as mean ± SD of three independent experiments. C. Western blot analysis of apoptosis-related proteins at the indicated time points following treatment with 10 nM cetuximab-vc-MMAF. Actin was used as a loading control, and molecular weight markers are shown at the right. D. Analysis of caspase-3 activity in cells treated with cetuximab-vc-MMAF (10 nM) for the indicated times. Data represent mean ± SD of fluorescence intensity resulting from substrate cleavage (Ac-DEVD-AFC) by activated caspase-3 in two independent experiments.
Techniques Used: Flow Cytometry, Apoptosis Assay, Western Blot, Control, Molecular Weight, Activity Assay, Fluorescence
Related Articles
Immunostaining:Article Title: Ganoderic acid A targets IL-1R1 and disrupts IL-1β binding in human cancer cells Article Snippet: Interleukin 1 (IL-1)-mediated tumor microenvironmental inflammation plays a significant role in cancer development.. Despite the recognition of interleukin-1β (IL-1β) and its receptor interleukin-1 receptor 1 (IL-1R1) as crucial targets for cancer treatment, their inhibitors have shown limited efficacy in clinical trials.. Ganoderma lucidum, a traditional Chinese medicine known for its health benefits, longevity promotion, and anti-cancer properties, has gained attention. Blocking Assay:Article Title: Ganoderic acid A targets IL-1R1 and disrupts IL-1β binding in human cancer cells Article Snippet: Interleukin 1 (IL-1)-mediated tumor microenvironmental inflammation plays a significant role in cancer development.. Despite the recognition of interleukin-1β (IL-1β) and its receptor interleukin-1 receptor 1 (IL-1R1) as crucial targets for cancer treatment, their inhibitors have shown limited efficacy in clinical trials.. Ganoderma lucidum, a traditional Chinese medicine known for its health benefits, longevity promotion, and anti-cancer properties, has gained attention. |